157 related articles for article (PubMed ID: 69691)
1. Parkinson's disease, melanoma, and levodopa.
Fermaglich J; Delaney P
J Neurol; 1977 Jun; 215(3):221-4. PubMed ID: 69691
[No Abstract] [Full Text] [Related]
2. Levodopa and melanoma: three cases and review of literature.
Rampen FH
J Neurol Neurosurg Psychiatry; 1985 Jun; 48(6):585-8. PubMed ID: 4009196
[TBL] [Abstract][Full Text] [Related]
3. Levodopa and melanoma.
Fermaglich J; Delaney P
JAMA; 1979 Mar; 241(9):883-4. PubMed ID: 762862
[No Abstract] [Full Text] [Related]
4. Impaired levodopa response in Parkinson's disease during melanoma therapy.
Merello M; Esteguy M; Perazzo F; Leiguarda R
Clin Neuropharmacol; 1992 Feb; 15(1):69-74. PubMed ID: 1576600
[TBL] [Abstract][Full Text] [Related]
5. Levodopa, melanoma, and Parkinson's disease.
Weiner WJ; Singer C; Sanchez-Ramos JR; Goldenberg JN
Neurology; 1993 Apr; 43(4):674-7. PubMed ID: 8469320
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?
Fiala KH; Whetteckey J; Manyam BV
Parkinsonism Relat Disord; 2003 Aug; 9(6):321-7. PubMed ID: 12853231
[TBL] [Abstract][Full Text] [Related]
7. Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature.
Kochar AS
Am J Med; 1985 Jul; 79(1):119-21. PubMed ID: 4014296
[TBL] [Abstract][Full Text] [Related]
8. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
Zanetti R; Loria D; Rosso S
Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
[TBL] [Abstract][Full Text] [Related]
9. [Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma].
Kleinhans M; Schmid-Grendelmeier P; Burg G
Hautarzt; 1996 Jun; 47(6):432-7. PubMed ID: 8767657
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease, levodopa-use and the risk of melanoma.
Vermeij JD; Winogrodzka A; Trip J; Weber WE
Parkinsonism Relat Disord; 2009 Sep; 15(8):551-3. PubMed ID: 19501540
[TBL] [Abstract][Full Text] [Related]
11. Levodopa therapy and malignant melanoma.
Sober AJ; Wick MM
JAMA; 1978 Aug; 240(6):554-5. PubMed ID: 671667
[TBL] [Abstract][Full Text] [Related]
12. [Melanomas and basal cell carcinomas in a patient with Parkinson disease].
Hiraldo A; Gómez-Moyano E; Martínez S; Sanz A
Actas Dermosifiliogr; 2010; 101(1):95-6. PubMed ID: 20109402
[No Abstract] [Full Text] [Related]
13. [Melanoma as a possible complication of the treatment of parkinsonism with L-dopa preparations (review of the literature)].
Kande'l EI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):126-7. PubMed ID: 2692357
[No Abstract] [Full Text] [Related]
14. Safety of long-term levodopa therapy in malignant melanoma.
Woofter MJ; Manyam BV
Clin Neuropharmacol; 1994 Aug; 17(4):315-9. PubMed ID: 9316678
[TBL] [Abstract][Full Text] [Related]
15. Uveal malignant melanoma and levodopa therapy in Parkinson's disease.
Van Rens GH; De Jong PT; Demols EE; Brihaye-Van Geertruyden MF
Ophthalmology; 1982 Dec; 89(12):1464-6. PubMed ID: 7162789
[No Abstract] [Full Text] [Related]
16. [Malignant melanoma and L-dopa. Review of literature on the problem of causal relationship].
Happle
Fortschr Med; 1974 Sep; 92(27):1065-6. PubMed ID: 4457419
[No Abstract] [Full Text] [Related]
17. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
Pfützner W; Przybilla B
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):332-6. PubMed ID: 9270541
[TBL] [Abstract][Full Text] [Related]
18. Levodopa therapy and the risk of malignant melanoma.
Siple JF; Schneider DC; Wanlass WA; Rosenblatt BK
Ann Pharmacother; 2000 Mar; 34(3):382-5. PubMed ID: 10917387
[TBL] [Abstract][Full Text] [Related]
19. Treatment with levodopa and risk for malignant melanoma.
Olsen JH; Tangerud K; Wermuth L; Frederiksen K; Friis S
Mov Disord; 2007 Jul; 22(9):1252-7. PubMed ID: 17534943
[TBL] [Abstract][Full Text] [Related]
20. Melanoma and levodopa.
Rampen F
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):782-4. PubMed ID: 9591833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
